These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

843 related items for PubMed ID: 9193189

  • 1. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL.
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [Abstract] [Full Text] [Related]

  • 2. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Nukui Y, Picozzi VJ, Traverso LW.
    Am J Surg; 2000 May; 179(5):367-71. PubMed ID: 10930481
    [Abstract] [Full Text] [Related]

  • 3. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
    Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB.
    J Clin Oncol; 1997 Mar; 15(3):928-37. PubMed ID: 9060530
    [Abstract] [Full Text] [Related]

  • 4. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Picozzi VJ, Kozarek RA, Traverso LW.
    Am J Surg; 2003 May; 185(5):476-80. PubMed ID: 12727570
    [Abstract] [Full Text] [Related]

  • 5. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
    Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD.
    J Gastrointest Surg; 2000 May; 4(6):567-79. PubMed ID: 11307091
    [Abstract] [Full Text] [Related]

  • 6. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.
    Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA.
    Ann Surg; 1995 Jun; 221(6):721-31; discussion 731-3. PubMed ID: 7794076
    [Abstract] [Full Text] [Related]

  • 7. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A, Abrams RA, Yeo CJ, Korman LT, Donehower RC, Hruban RH, Zahurek ML, Grochow LB, O'Reilly S, Hurwitz H, Jaffee EM, Lillemoe KD, Cameron JL.
    Int J Radiat Oncol Biol Phys; 2000 Nov 01; 48(4):1089-96. PubMed ID: 11072167
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
    Hsu CC, Herman JM, Corsini MM, Winter JM, Callister MD, Haddock MG, Cameron JL, Pawlik TM, Schulick RD, Wolfgang CL, Laheru DA, Farnell MB, Swartz MJ, Gunderson LL, Miller RC.
    Ann Surg Oncol; 2010 Apr 01; 17(4):981-90. PubMed ID: 20087786
    [Abstract] [Full Text] [Related]

  • 9. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.
    Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB.
    Ann Surg Oncol; 2001 Mar 01; 8(2):123-32. PubMed ID: 11258776
    [Abstract] [Full Text] [Related]

  • 10. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
    Abrams RA, Grochow LB, Chakravarthy A, Sohn TA, Zahurak ML, Haulk TL, Ord S, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL, Yeo CJ.
    Int J Radiat Oncol Biol Phys; 1999 Jul 15; 44(5):1039-46. PubMed ID: 10421536
    [Abstract] [Full Text] [Related]

  • 11. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN, Rao AS, Rani Anne P, Rosato FE, Rosato EL, Andrel J, Hyslop T, Xu X, Berger AC.
    Ann Surg Oncol; 2009 Aug 15; 16(8):2116-22. PubMed ID: 19437078
    [Abstract] [Full Text] [Related]

  • 12. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
    Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB.
    J Clin Oncol; 1998 Dec 15; 16(12):3843-50. PubMed ID: 9850029
    [Abstract] [Full Text] [Related]

  • 13. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
    Pendurthi TK, Hoffman JP, Ross E, Johnson DE, Eisenberg BL.
    Am Surg; 1998 Jul 15; 64(7):686-92. PubMed ID: 9655283
    [Abstract] [Full Text] [Related]

  • 14. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas.
    Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG, Rosato EF.
    Int J Radiat Oncol Biol Phys; 2000 Jul 01; 47(4):945-53. PubMed ID: 10863064
    [Abstract] [Full Text] [Related]

  • 15. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA.
    Int J Radiat Oncol Biol Phys; 2002 Apr 01; 52(5):1293-302. PubMed ID: 11955742
    [Abstract] [Full Text] [Related]

  • 16. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
    White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz H, Tyler D.
    Ann Surg Oncol; 1999 Apr 01; 6(1):38-45. PubMed ID: 10030414
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer.
    Penberthy DR, Rich TA, Shelton CH, Adams R, Minasi JS, Jones RS.
    Ann Oncol; 2001 May 01; 12(5):681-4. PubMed ID: 11432628
    [Abstract] [Full Text] [Related]

  • 18. Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation.
    Evans DB, Abbruzzese JL, Cleary KR, Buchholz DJ, Fenoglio CJ, Collier C, Rich TA.
    Int J Radiat Oncol Biol Phys; 1995 Nov 01; 33(4):913-8. PubMed ID: 7591902
    [Abstract] [Full Text] [Related]

  • 19. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.
    Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB.
    Am J Surg; 1996 Jan 01; 171(1):118-24; discussion 124-5. PubMed ID: 8554125
    [Abstract] [Full Text] [Related]

  • 20. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH.
    Ann Surg; 2002 Sep 01; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.